Evaluation of lung metabolism during successful twenty-four-hour canine lung preservation. 1993

H Date, and A Matsumura, and J K Manchester, and H Obo, and O Lima, and J M Cooper, and S Sundaresan, and O H Lowry, and J D Cooper
Department of Surgery, Washington University School of Medicine, Barnes Hospital, St. Louis, Mo.

We used a canine left lung allotransplantation model to evaluate 24-hour lung preservation with two different electrolyte solutions, low-potassium dextran and low-potassium dextran with 1% glucose. To investigate changes in the energy status during preservation, we analyzed the lungs for adenosine triphosphate, phosphocreatine, and several metabolites of the glycolysis pathway and the citric acid cycle: glucose, glucose-6-phosphate, lactate, citrate, and malate. We also devised and evaluated a pulmonary cooling jacket to prevent rewarming of the lung during implantation. The lungs were divided into four groups. Groups I (n = 10) and II (n = 6) were flushed with low-potassium dextran and groups III (n = 6) and IV (n = 6) were flushed with low-potassium dextran solution with 1% glucose. The cooling jacket was used for groups II and IV only. After 24-hour preservation at 10 degrees C, the left lungs were implanted into the recipient animals. Function of the transplanted left lung was assessed during temporary (10 minutes) occlusion of the contralateral pulmonary artery while both lungs were ventilated with 100% oxygen. This assessment was performed at 1 hour and at 3, 8, and 22 days after transplantation. Immediately after transplantation the arterial oxygen tension was 279 +/- 70 mm Hg in group I, 376 +/- 56 mm Hg in group II, 523 +/- 41 mm Hg in group III, and 518 +/- 50 mm Hg in group IV. The arterial oxygen tension in groups III and IV were significantly greater than in group I (p < 0.05). Of the lungs preserved with low-potassium dextran solution with 1% glucose solution, 11 of 12 (92%) showed excellent lung function (arterial oxygen tension > 300 mm Hg) at 3 days; only 10 of 16 lungs preserved with low-potassium dextran achieved this level of function. Glucose, glucose-6-phosphate, lactate, citrate and malate levels decreased significantly during 24-hour preservation with low-potassium dextran solution; they were stable with low-potassium dextran solution with 1% glucose. Adenosine triphosphate and phosphocreatine were stable for 24 hours with both low-potassium dextran and low-potassium dextran solution with 1% glucose. The cooling jacket provided uniform cooling of the lung parenchyma during implantation, and significant increase in temperature was observed in its absence, with topical cooling by cold saline solution.(ABSTRACT TRUNCATED AT 400 WORDS)

UI MeSH Term Description Entries
D007036 Hypothermia, Induced Abnormally low BODY TEMPERATURE that is intentionally induced in warm-blooded animals by artificial means. In humans, mild or moderate hypothermia has been used to reduce tissue damages, particularly after cardiac or spinal cord injuries and during subsequent surgeries. Induced Hypothermia,Mild Hypothermia, Induced,Moderate Hypothermia, Induced,Targeted Temperature Management,Therapeutic Hypothermia,Hypothermia, Therapeutic,Induced Mild Hypothermia,Induced Mild Hypothermias,Induced Moderate Hypothermia,Induced Moderate Hypothermias,Mild Hypothermias, Induced,Moderate Hypothermias, Induced,Targeted Temperature Managements
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D009926 Organ Preservation The process by which organs are kept viable outside of the organism from which they were removed (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism). Organ Preservations,Preservation, Organ,Preservations, Organ
D010725 Phosphocreatine An endogenous substance found mainly in skeletal muscle of vertebrates. It has been tried in the treatment of cardiac disorders and has been added to cardioplegic solutions. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1996) Creatine Phosphate,Neoton,Phosphocreatine, Disodium Salt,Phosphorylcreatine,Disodium Salt Phosphocreatine,Phosphate, Creatine
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D002951 Citrates Derivatives of CITRIC ACID.
D003911 Dextrans A group of glucose polymers made by certain bacteria. Dextrans are used therapeutically as plasma volume expanders and anticoagulants. They are also commonly used in biological experimentation and in industry for a wide variety of purposes. Dextran,Dextran 40,Dextran 40000,Dextran 70,Dextran 75,Dextran 80,Dextran B-1355,Dextran B-1355-S,Dextran B1355,Dextran B512,Dextran Derivatives,Dextran M 70,Dextran T 70,Dextran T-40,Dextran T-500,Hemodex,Hyskon,Infukoll,Macrodex,Polyglucin,Promit,Rheodextran,Rheoisodex,Rheomacrodex,Rheopolyglucin,Rondex,Saviosol,Dextran B 1355,Dextran B 1355 S,Dextran T 40,Dextran T 500
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug

Related Publications

H Date, and A Matsumura, and J K Manchester, and H Obo, and O Lima, and J M Cooper, and S Sundaresan, and O H Lowry, and J D Cooper
January 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
H Date, and A Matsumura, and J K Manchester, and H Obo, and O Lima, and J M Cooper, and S Sundaresan, and O H Lowry, and J D Cooper
March 1991, Transplantation,
H Date, and A Matsumura, and J K Manchester, and H Obo, and O Lima, and J M Cooper, and S Sundaresan, and O H Lowry, and J D Cooper
June 1974, The Journal of surgical research,
H Date, and A Matsumura, and J K Manchester, and H Obo, and O Lima, and J M Cooper, and S Sundaresan, and O H Lowry, and J D Cooper
January 1968, Transactions - American Society for Artificial Internal Organs,
H Date, and A Matsumura, and J K Manchester, and H Obo, and O Lima, and J M Cooper, and S Sundaresan, and O H Lowry, and J D Cooper
January 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
H Date, and A Matsumura, and J K Manchester, and H Obo, and O Lima, and J M Cooper, and S Sundaresan, and O H Lowry, and J D Cooper
January 1996, Transplant international : official journal of the European Society for Organ Transplantation,
H Date, and A Matsumura, and J K Manchester, and H Obo, and O Lima, and J M Cooper, and S Sundaresan, and O H Lowry, and J D Cooper
January 1975, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes,
H Date, and A Matsumura, and J K Manchester, and H Obo, and O Lima, and J M Cooper, and S Sundaresan, and O H Lowry, and J D Cooper
February 1999, Transplantation,
H Date, and A Matsumura, and J K Manchester, and H Obo, and O Lima, and J M Cooper, and S Sundaresan, and O H Lowry, and J D Cooper
May 1985, The Journal of heart transplantation,
H Date, and A Matsumura, and J K Manchester, and H Obo, and O Lima, and J M Cooper, and S Sundaresan, and O H Lowry, and J D Cooper
February 1987, Transplantation proceedings,
Copied contents to your clipboard!